Cited by 44Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and OutcomesSchizophrenia research and treatment

A randomized controlled multicenter trial on the multimodal treatment of adult attention-deficit hyperactivity disorder: enrollment and characteristics of the study sample

Philipsen, Alexandra, Graf, Erika, Jans, Thomas, Matthies, Swantje, Borel, Patricia, Colla, Michael, Gentschow, Laura, Langner, Daina +16 more·2014·ADHD Attention Deficit and Hyperactivity Disorders

Abstract

Adult ADHD is a frequent psychiatric disorder affecting relevant aspects of an individual's life. The aim of our study group was to carry out the first randomized controlled multicenter study to evaluate the effects of psychotherapy compared to clinical management in combination with psychopharmacological treatment with methylphenidate (MPH) or placebo (Plac) in a factorial four-arm design. Here, we present the enrollment procedure and description of adult ADHD patients recruited for the trial. Four hundred and thirty-three adult patients with ADHD were randomized at seven study sites in Germany to four treatment conditions: manualized dialectical-behavioral-therapy-based group psychotherapy (GPT) plus MPH or Plac, or clinical management (CM) including supportive counseling plus MPH or Plac with weekly sessions in the first 12 weeks and monthly sessions thereafter. Assessment for eligibility included standardized scales and instruments. After prescreening of 1,480 patients, 518 were evaluated for trial participation and 433 were randomized. The main reasons for prescreening failure were lack of interest in participating (n = 205), difficulties in meeting the time and effort requirements for participation (n = 186), and contraindications for psychopharmacological treatment with MPH (n = 194). The full analysis set (FAS) comprised 419 adult ADHD patients (mean age 35.2 years, males/females 1:1). Fifty-seven percent of the patients suffered from the combined ADHD subtype. Prevalence of at least one current or lifetime axis-I comorbidity was 66 %. Axis-II comorbidity rates was 18 % (patients with comorbid borderline and antisocial personality disorders were excluded). Our network was able to recruit an adult ADHD sample essentially comparable to community samples. A selection bias was created by excluding patients unable or unwilling to participate, or who had somatic and psychiatric contraindications for stimulant treatment (Current Controlled Trials ISRCTN54096201, FUNDING: Federal Ministry of Education and Research 01GV0606).

Integrity signals

Registry

Crossref · 10.1007/s12402-013-0120-z

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Philipsen, A., Graf, E., Jans, T., Matthies, S., Borel, P., Colla, M., Gentschow, L., Langner, D., Jacob, C., Groß-Lesch, S., Sobanski, E., Alm, B., Schumacher-Stien, M., Roesler, M., Retz, W., Retz-Junginger, P., Kis, B., Abdel-Hamid, M., Heinrich, V., Huss, M., Kornmann, C., Bürger, A., van Elst, L. T., & Berger, M.
Affiliations
  • University Medical Center Freiburg (DE)
  • Universitätsklinikum Würzburg (DE)
  • Stiftung Charité (DE)
  • Central Institute of Mental Health (DE)
  • Universitätsklinikum des Saarlandes (DE)
  • University of Duisburg-Essen (DE)
  • University Medical Center of the Johannes Gutenberg University Mainz (DE)
Corresponding author
Philipsen, Alexandra
Venue
ADHD Attention Deficit and Hyperactivity Disorders
Published
2013-10-17
Volume
6
Issue
1
Pages
35-47
ISSN
  • 1866-6116 (ISSN-L)
  • 1866-6647
OpenAlex
W2086121543
Cited by
44
References
45
Citations by year
2026: 1 · 2025: 4 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 4 · 2020: 2 · 2019: 4 · 2018: 3 · 2017: 4 · 2016: 4 · 2015: 5 · 2014: 4
FWCI
3.07
Type
journal article
Language
en
Open access
closed
Locations
  • ADHD Attention Deficit and Hyperactivity Disorders (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Eli Lilly and Company
  • Bundesministerium für Bildung und Forschung
  • Commercializations Promotion Agency for R and D Outcomes
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
adult ADHD, multimodal therapy, methylphenidate, psychopharmacological treatment, dialectical behavior therapy, group therapy, clinical management, trial recruitment, selection bias, comorbidities, factorial design
MeSH terms
Adult, Attention Deficit Disorder with Hyperactivity, Behavior Therapy, Mental Disorders, Clinical Protocols, Combined Modality Therapy, Female, Germany, Humans, Male, Methylphenidate, Psychotherapy, Group, Comorbidity, Patient Selection, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review